AWAKN LIFE SCIENCES CORP News

CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)

Toronto, Ontario--(Newsfile Corp. - Le 31 mai/May 2024) - Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the

newsfileMay 31 10:14

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati

BenzingaApr 17 08:13

Awakn Life Sciences Inks Licensing Partnership Deal With Oklahoma-based Clinic

Seeking AlphaApr 3 07:41

Canadian Securities Exchange Reports February 2024 Performance Figures

Yahoo FinanceMar 15 06:41

Canadian Securities Exchange Welcomes Listing of Awakn Life Sciences Corp

Yahoo FinanceFeb 13 14:00

CSE Bulletin: New Listing - Awakn Life Sciences Corp. (AWKN)

Toronto, Ontario--(Newsfile Corp. - Le 9 février/February 2024) - The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure documents will be av

newsfileFeb 12 12:52

Awakn Life Sciences Announces Conditional Approval of CSE Listing

Yahoo FinanceFeb 5 06:30

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Yahoo FinanceJan 14 13:04

Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More

GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan Vivek Ramaswamy, who famously said he did not approve of Ohio's cannabis initiative last week despite

BenzingaNov 24, 2023 08:44

UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center

The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ:CMPS) for Treatment-Resistant Depression and Awakn Life S

BenzingaNov 15, 2023 15:20

U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy

Professor David Nutt, a cognitive sciences, addiction, cannabis and psychedelics researcher, has been ranked the #1 psychopharmacologist by ScholarGPS, a California-based American company owned and op

BenzingaOct 15, 2023 19:06